Skip to main content

Table 1 Demographic and clinical characteristics of study participants in two groups

From: Does the “delayed start” protocol with gonadotropin-releasing hormone antagonist improve the pregnancy outcome in Bologna poor responders? a randomized clinical trial

Variables

Control group (N = 60)

Delayed start group (N = 60)

P value

Female age (yr.)

39.5 ± 4.8

40.5 ± 4.48

0.2

Body mass index (kg/m2)

26.1 ± 3.2

26.8 ± 3.0

0.2

Duration of Infertility (yr.)

9.2 ± 6.7

7.9 ± 5.2

0.2

No. of couple with primary infertility n (%)

44 (73.3)

42 (70.0)

0.8

Early follicular phase FSH (IU/L)

8.7 ± 3.3

8.0 ± 2.8

0.3

Early follicular phase LH (IU/L)

5.5 ± 4.2

6.5 ± 4.5

0.1

Early follicular phase AMH (ng/mL)

0.53 ± 0.31

0.55 ± 0.30

0.8

Serum level of TSH (IU/mL)

1.7 ± 0.8

1.9 ± 1.1

0.2

Serum level of Prolactin (ng/mL)

17.8 ± 10.0

17.8 ± 8.7

0.6

Antral follicle count

5.0 ± 1.8

4.7 ± 1.2

0.3

No. of previous failed cycles

1.5 ± 1.2

1.3 ± 1.0

0.1

Subgroups of POR according to Bologna criteria n, (%)

  

0.2

Subgroup A

0

0

 

Subgroup B

18 (30)

19 (31.7)

 

Subgroup C

18 (30)

10 (16.6)

 

Subgroup D

24 (40)

31 (51.7)

 
  1. Descriptive data were presented as Mean ± SD. P-value≤0.05 was considered statistically significant
  2. No number, FSH Follicle stimulating hormone, LH = Luteinizing hormone, TSH = Thyroid stimulating hormone, AMH Anti-müllerian hormone, E2 = estradiol, P = Progesterone
  3. Subgroup A: (female age ≥ 40, and a previous poor response (cycle cancelled or ≤ 3 oocytes)
  4. Subgroup B: female age ≥ 40 with an abnormal antral follicle count (AFC) < 7 and AMH level
  5. Subgroup C: abnormal AFC < 7 and AMH < 1.1 ng/ ml with a previous poor response
  6. Subgroup D: female age ≥ 40 with an AFC < 7 and AMH < 1.1 ng/ ml and previous poor response